Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes
Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes
Active, not recruiting · NCT05949281 · Registry updated 2026-07-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes | Nutritional and Metabolic Diseases, autoimmune disease, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Active, not recruiting | Phase 2 | 2026-07-13 | NCT05949281 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Asger Lund, MD | 3 |
| Juvenile Diabetes Research Foundation | 33 |
| University of Copenhagen | 170 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Center for Clinical Metabolic Research, Gentofte Hospital | Hellerup | Denmark | 4 |